Europe Pharmaceutical Analytical Testing Outsourcing Market Report 2022: Rising Pipelines for Drug Candidates and Growing Demand for Additional Drug Analytical Details Driving 8.4% Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The report “Europe Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type, Product Type, End-User, Organization Size, and Country: Trend Forecast and Growth Opportunity” has been added to from ResearchAndMarkets.com offer.

The European pharmaceutical analytical testing outsourcing market was valued at $1,919.1 million in 2021 and will grow at 8.4% pa over the period 2021-2031, driven by the increase in drug candidate pipelines , the growing demand for additional analytical drug details as well as the development of processes by regulatory authorities. agencies, the entry of new contractual organizations and the lack of internal equipment as well as the growing adoption of outsourcing activities.

In-depth qualitative analyzes include the identification and investigation of the following aspects:

  • Market structure

  • Growth engines

  • Constraints and challenges

  • Emerging Product Trends and Market Opportunities

  • Porter’s Five Forces

On the basis of service type, the Europe market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Bioanalytical tests

  • Clinical tests

  • Non-clinical trials

  • Method development and validation

  • Extractable and leachable

  • Impurity method

  • Technical advice

  • Other methods

  • Stability test

  • Drug testing

  • Accelerated stability testing

  • Photostability test

  • Other stability tests

  • Other services

On the basis of product, the Europe market is segmented into the following submarkets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Raw materials and additives

  • Active Pharmaceutical Ingredients (API)

  • Finished products

By end-user, the Europe market is segmented into the following submarkets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Pharmaceutical and biopharmaceutical companies

  • Contract Manufacturing Organizations (CMOs)

  • Other end users

By organization size, the Europe market is segmented into the following submarkets with annual revenue (USD Million) for 2021-2031 included in each section.

Geographically, the following national/local markets are fully investigated:

  • Germany

  • UK

  • France

  • Spain

  • Italy

  • Netherlands

  • Rest of Europe (segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark and Finland)

Selected key players:

  • Boston Analytical, Inc.

  • Charles River International Laboratories, Inc.

  • Eurofins Scientific SE

  • Exova Group PLC

  • Intertek Pharmaceutical Services

  • Testing laboratory inc.

  • Pace Analytical Services LLC

  • Pharmaceutical Product Development, LLC

  • SGS S.A.

  • Steris PLC

  • Tentamus

  • Toxicon inc.

  • West Pharmaceutical Services Inc.

  • WuXi AppTec, Inc.

Main topics covered:

1. Introduction

2 Market Overview and Dynamics

3 Europe Market Segmentation by Type of Service

4 Europe Market Segmentation by Product Type

5 Europe Market Segmentation by End User

6 Europe Market Segmentation by Organization Size

7 Europe Market 2021-2031 by Country

8 Competitive Landscape

Companies cited

  • Boston Analytical, Inc.

  • Charles River International Laboratories, Inc.

  • Eurofins Scientific SE

  • Exova Group PLC

  • Intertek Pharmaceutical Services

  • Testing laboratory inc.

  • Pace Analytical Services LLC

  • Pharmaceutical Product Development, LLC

  • SGS S.A.

  • Steris PLC

  • Tentamus

  • Toxicon inc.

  • West Pharmaceutical Services Inc.

  • WuXi AppTec, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/jfqxcn